The guidewire’s functionality is designed to allow for comprehensive data collection and analysis and facilitates data necessary for AI decision-making tools.
Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.
Improved functionality across four valve sizes and lowest delivery profile on market, Evolut PRO+ TAVR System launches in U.S. as TAVR patient population grows.
Decision expands access to TAVR by modernizing requirements providers must meet to perform the cardiac procedure under Coverage with Evidence Development (CED).